Carregant...
A dose-finding study of carboplatin–epirubicin–docetaxel in advanced epithelial ovarian cancer
The docetaxel–carboplatin combination is active and well tolerated in patients with epithelial ovarian cancer. We added epirubicin to this combination to investigate additional benefits of anthracyclines in epithelial ovarian cancer. Twenty-one patients, FIGO Ic-IV, performance status 0–1, were trea...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2375366/ https://ncbi.nlm.nih.gov/pubmed/11986768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600259 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|